Apathy is found in almost 80 per cent of late-stage cancer patients. A new study, conducted on mice reveals that apathy is ...

Cachexia not only contributes to reduced quality of life but also limits a patient’s ability to tolerate or benefit from ...

New research published in Science suggests apathy and lack of motivation are symptoms of a condition called cancer cachexia.

Scientists identify a brain pathway linking inflammation to fatigue, low energy, and loss of motivation in advanced cancer patients.

Following promising phase 1 data, TCMCB07 is being further evaluated in a phase 2 trial for the treatment of patients with ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.

This symptom is part of a syndrome called cachexia, which affects about 80% of late-stage cancer patients, leading to severe muscle wasting and weight loss that leave patients bone thin despite ...

This loss of motivation doesn’t just deepen patients’ suffering, it isolates them from family and friends. Because patients ...

Advanced cancer often leads to cachexia, a syndrome causing profound apathy in patients. New research reveals that cancer hijacks brain circuits controlling motivation, suggesting potential treatments ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in once-cherished activities. This symptom is part of a syndrome called cachexia ...